PERRI ROSE C 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Jan 3, 2011
Insider Transaction Report
Form 4
PERRI ROSE C
DirectorCOO, CFO, Treas. & Secy.
Transactions
- Exercise/Conversion
Common Stock
2011-01-03$0.00/sh+576,752$577→ 1,035,478 total - Exercise/Conversion
Common Stock Purchase Option (right to buy)
2011-01-03−576,752→ 0 totalExercise: $0.00From: 2005-04-05Exp: 2014-10-26→ Common Stock (576,752 underlying)
Holdings
- 341,496(indirect: By EBI, Inc.)
Common Stock
- 1,451,246(indirect: By Estate of Mark Perri)
Common Stock
- 953,667(indirect: By GHI, Inc.)
Common Stock
Footnotes (5)
- [F1]This aggregate number of shares does not include 200,000 shares of common stock underlying stock options which survived the death of Mark Perri, who was the reporting person's brother.
- [F2]The reporting person may be deemed to beneficially own such 341,496 shares owed of record by EBI, Inc. because the reporting person holds the right to vote such shares.
- [F3]The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. by reason of the reporting person's ownership of investment power and other economic benefits associated with such shares.
- [F4]The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. because the reporting person holds the right to vote such shares.
- [F5]The expiration date was extended through October 26, 2014 as previously reported in the issuer's Current Report on Form 8-K filed on October 23, 2009.